Increased fumarate and decreased iron levels in Fh-deficient cancer cells inactivate prolyl hydroxylases, leading to stabilization of hypoxia-inducible factor (HIF)-1α and increased expression of genes such as VEGF and glucose transporter 1 (GLUT1) to provide fuel needed for rapid growth demands. The gene discussed is FH; the disease is cancer.